Classifying female pattern hair loss requires a different framework than the Norwood scale used for men, because female patterns differ fundamentally, typically diffuse thinning of the central scalp with preservation of the frontal hairline. The Ludwig scale, introduced by Erich Ludwig in 1977, divides progression into three stages: I (frontal/parietal thinning with preserved frontal hair density), II (more pronounced central thinning), and III (visible scalp through hair across most of the central scalp).

The Sinclair scale, developed in 2004, provides finer-grained five-stage classification (1–5) that has been increasingly adopted in clinical trials because it offers better sensitivity to treatment response. Stage 1 represents normal density, stage 5 represents extensive diffuse thinning. Trials of low-dose oral minoxidil and spironolactone routinely use Sinclair staging for inclusion criteria and outcome measurement, which has standardised research reporting in ways the Ludwig scale couldn't.

Both scales remain in clinical use. Ludwig staging is more familiar to general dermatologists and patients. Sinclair staging is preferred by hair specialists for its sensitivity to subtle change. Neither scale captures the full diversity of female pattern presentations, particularly cases with more frontal-dominant pattern (Olsen 'Christmas tree' pattern), which are not well-represented in either framework. Combined visual assessment with trichoscopy provides the most clinically useful evaluation.